These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17620886)

  • 1. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
    Voon V; Potenza MN; Thomsen T
    Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-related impulse control and repetitive behaviors in Parkinson disease.
    Voon V; Fox SH
    Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE; Thompson PD; Kiley MA
    J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced impulse control disorders in Parkinson's disease.
    Reiff J; Jost WH
    J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impulse control disorders in Parkinson's disease].
    Joutsa J; Kaasinen V
    Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
    Ahlskog JE
    Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
    Fenu S; Wardas J; Morelli M
    Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
    Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
    J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
    Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
    Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
    Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    McKeon A; Josephs KA; Klos KJ; Hecksel K; Bower JH; Michael Bostwick J; Eric Ahlskog J
    Parkinsonism Relat Disord; 2007 Dec; 13(8):516-9. PubMed ID: 17544807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
    Ardouin C; Chéreau I; Llorca PM; Lhommée E; Durif F; Pollak P; Krack P;
    Rev Neurol (Paris); 2009 Nov; 165(11):845-56. PubMed ID: 19683776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders in Parkinson's disease in a Chinese population.
    Fan W; Ding H; Ma J; Chan P
    Neurosci Lett; 2009 Nov; 465(1):6-9. PubMed ID: 19560522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compulsive eating and weight gain related to dopamine agonist use.
    Nirenberg MJ; Waters C
    Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic dysregulation syndrome in Parkinson's disease.
    Katzenschlager R
    J Neurol Sci; 2011 Nov; 310(1-2):271-5. PubMed ID: 21868039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.